According to Paulo Teixeira, Brazil’s policy change to authorize industrial hemp and medical cannabis cultivation will be tabled in the Lower House for its first discussion. This chamber will accent the reform before the end of December.
Teixeira, the leader of the Lowe House medical marijuana commission, added that the bill hasn’t progressed recently thanks to the nation’s municipal elections which compromised parliamentary operations.
The elections were initially slated for October but the covid19 pandemic delayed them. They were concluded towards late November.
The official said that he expects Brazil’s lower house to quickly commence debating and accent the bill before the end of December now that elections have been wrapped up.
The bill, named 399/2015, will carry far-reaching effects for Latin America’s biggest medical marijuana market. The market has been explicitly reliant on imports.
One of the most significant arguments of the cultivation reform is the current skyrocketing price of Brazil’s imported medical marijuana. Proponents asserted that local farmers can supply medical marijuana at a reduced cost.
Teixeira was positive about the bill being accented by the senate sometime next year. The legislator asserted that he doesn’t expect major alterations to the bill’s text will be necessary for making political interferences and will be satisfactory to the sceptics.
On the question about the possibility of President Jair Bolsonaro opposing the bill, Teixeira stated that it will be hard for the head of state to rebuff what Brazil desires. He adds that if the president dissents the bill, they’ll gather enough support from the locals to surpass his veto.
Next week, Conitec ( the National Committee for Health Technology incorporation) will hold a summit to discuss the addition of one specific CBD formulation in SUS( Public Health System).
A final move is expected early next year that’ll make patients eligible for public health cover for the CBD formulation.